← Back to headlines
Hims & Hers Stock Rallies on Peptide Pipeline and Novo Nordisk Deal Hopes
Hims & Hers shares surged 9% as investors showed strong confidence in the company's peptide pipeline and a potential deal with Novo Nordisk.
20 Apr, 14:40 — 20 Apr, 14:40
Sources
Showing 1 of 1 sources
